Associate Physician, Brigham and Women's Hospital • Staff Physician, Dana-Farber Cancer Institute
Infectious Disease
Dr. Francisco Marty, MD
|
|
Give Review
Francisco Marty is an expert in the field of Infectious Disease. He attended Albert Einstein College of Medicine. He has 14 awards "Best Abstracts Award", "CID Top Article Award", "First Prize, Poster Competition", "Program Committee Award", "Partners in Excellence Award", "Faculty Mentor Award", "Faculty Teaching Award", "Clinical Infectious Diseases Award for Outstanding Review", "Charles C. Shepard Award, Nomination", "Physician Recognition Award", "Excellence in Teaching Award for Residents & Fellows", "American Medical Association", "Leo M. Davidoff Society Award for Medical Student Teaching" and "Full Scholarship". Francisco Marty is also a published doctor. He has 100 publication published. The most recent publication is: Guillain-Barr syndrome associated with resistant cytomegalovirus infection after face transplantation. Dr. Francisco Marty is registered with Medicare and accepts Medicare payments.
Publications
- Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.
- Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.
- Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer.
- Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
- Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
- Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis.
- Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience.
- Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation.
- Serious infections among adult medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
- Risk factors for invasive fungal disease in heart transplant recipients.
- BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.
- A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis.
- CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit candidate vaccine in adult autologous hematopoietic stem-cell transplant recipients.
- Cord colitis syndrome in cord-blood stem-cell transplantation.
- Three patients with full facial transplantation.
- Reply to "insufficient demonstration of long-term stability of Aspergillus galactomannan".
- Triple opportunistic pulmonary cavitary disease after cord blood transplantation.
- Serologic response to hepatitis B vaccination among lung transplantation candidates.
- Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
- Utility of sentinel flaps in assessing facial allograft rejection.
- The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant.
- The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?
- Abstract 59: face transplantation in a highly sensitized recipient.
- Long-term stability at -20{degrees} C of Aspergillus GM in serum and bronchoalveolar lavage specimens.
- Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease.
- Isavuconazole treatment of a patient with disseminated mucormycosis.
- Cefepime versus other antibacterial agents for the treatment of Enterobacter species bacteremia.
- Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy.
- Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.
- Cost analysis of dental services needed before hematopoietic cell transplantation.
- DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation.
- BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis.
- Bradyrhizobium enterica in cord colitis syndrome.
- Incidence and risk factors for herpes zoster following heart transplantation.
- Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study.
- Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.
- Development and Evaluation of a Calibrator Material for Nucleic Acid-based Assays for Diagnosing Aspergillosis.
- Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thorac...
- Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient.
- Neutropenia associated with prolonged daptomycin use.
- Vascularized composite tissue allotransplantation - state of the art.
- Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.
- Infections following facial composite tissue allotransplantation--single center experience and review of the literature.
- Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
- Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
- Invasive Mycoleptodiscus fungal cellulitis and myositis.
- Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods.
- Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
- Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients.
- A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease after Lung Transplantation: A Sequential Cohort Analysis.
- Post-diagnostic kinetics of the (1 --> 3)-beta-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
- Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
- Serum Galactomannan and (1->3) ?-D-Glucan Assays in Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.
- Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis 2001-2009.
- Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
- How do we manage oral infections in allogeneic stem cell transplantation and other severely immunocompromised patients?
- Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation.
- Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
- Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia.
- Pandemic H1N1 Influenza Infection in Adult Transplant Recipients.
- Molecular Methods to Improve the Diagnosis and Identification of Mucormycosis.
- Gordonia bronchialis Bacteremia and Pleural Infection: Case Report and Review of the Literature.
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomi...
- HIV-1 and 2009 H1N1 influenza A in adults.
- Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
- Infectious complications associated with immunomodulating biologic agents.
- Invasive fungal disease after remote inoculation in transplant recipients.
- Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
- Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.
- Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
- Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review.
- Transplant infectious disease as a subspecialty: does outlining how we train define who we are?
- Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
- Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential...
- Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature.
- Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis.
- Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report.
- Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
- Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies.
- Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the liter...
- Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
- Strongyloides hyperinfection syndrome and transplantation: a preventable, frequently fatal infection.
- Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.
- Positively false.
- Human herpesvirus 6 encephalitis.
- Recovery of Herbaspirillum species from persons with cystic fibrosis.
- Persistent and relapsing babesiosis in immunocompromised patients.
- Management of oral infections in cancer patients.
- Posaconazole for invasive aspergillosis?
- Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
- (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.
- Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort ...
- Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospe...
- Torsades de pointes associated with voriconazole use.
- Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.
- The persistent challenges of bacterial infections in the transplant recipient.
- Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
- Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
Schools
Universidad Central De VenezuelaJose Maria Vargas Escuela De Medicina Jose Maria Vargas
Albert Einstein College Med
Mass Genl Hospital Brigham and Women39s Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Best Abstracts Award
- CID Top Article Award
- First Prize, Poster Competition
- Program Committee Award
- Partners in Excellence Award
- Faculty Mentor Award
- Faculty Teaching Award
- Clinical Infectious Diseases Award for Outstanding Review
- Charles C. Shepard Award, Nomination
- Physician Recognition Award
- Excellence in Teaching Award for Residents & Fellows
- American Medical Association
- Leo M. Davidoff Society Award for Medical Student Teaching
- Full Scholarship
Education
-
Harvard School of Public Health -
Massachusetts General Hospital -
Brigham and Women's Hospital -
Albert Einstein College of Medicine -
Central University of Venezuela
Hospital
-
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1710940283 | |
| NPPES Provider LastName | MARTY | |
| NPPES Provider FirstName | FRANCISCO | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 212.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 5.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710940283 |
| Last Name Of The Provider | MARTY |
| First Name Of The Provider | FRANCISCO |
| View All |
Similar Doctors
|
|
Dr. Regina C. Larocque, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicolas C. Issa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Thomas Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claudia M. Denkinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary T. Lasalvia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne G. Kasmar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sophia Koo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander D. Macalalad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Bebell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee M. Wetzler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richa Tandon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica Manandhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Margaret M. Sullivan, FNP
This Doctor is OpenDoctor Recommended.
|